We’re starting into 2021 with very good news: Our collaborative Grant proposal « PREDICT » (co-investigators: Prof. Vincent Zoete, Prof. Niklaus Schaefer) has been accepted by the San Salvatore Foundation and will receive funding for 2021-2023 !
Proud to announce: Our collaborative Oncosuisse Grant proposal « RADIATION » (co-investigators: Dr. Steven Dunn, Dr. Melita Irving, Prof. Vincen Zoete) has been accepted and will receive funding for 2021-2023 !
We recommend the recently published review of Professor Magret Schottelius addressing the role of CXCR4 in cancer:
We gratulate Prof Magret Schottelius for the new promising publication:
A clinical study performed with [99mTc]Tc-PSMA I&S is accessible now:
Finally! The first important step is accomplished. We now have a fully equipped laboratory, and this milestone is celebrated with a classical Swiss Apéro. The lab is now officially ready for synthesis and first preclinical experiments.
Thanks to all those who have supported us!
A new publication highlights an underestimated preclinical issue:
We welcome Severin as new member in our research team. With his previous experience as a radiochemist, he will be a great asset to establish our research group. Finally, we wish him a pleasant scientific start in Lausanne.
First equipment arrives, our lab grows now from day to day - and we will be soon ready to cook (synthesize) :)
We welcome Sebastian as new PhD candidate in the TRS research group and whish him a pleasant scientific start in the new lab!
The TRS (Translational Radiopharmaceutical Sciences) research group is established and ready to get started under the expertise of Prof. Dr. Margret Schottelius.